{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T14:18:56Z","timestamp":1770992336611,"version":"3.50.1"},"publisher-location":"Berlin, Heidelberg","reference-count":54,"publisher":"Springer Berlin Heidelberg","isbn-type":[{"value":"9783642701429","type":"print"},{"value":"9783642701405","type":"electronic"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1985]]},"DOI":"10.1007\/978-3-642-70140-5_18","type":"book-chapter","created":{"date-parts":[[2011,10,25]],"date-time":"2011-10-25T18:06:39Z","timestamp":1319565999000},"page":"137-144","source":"Crossref","is-referenced-by-count":4,"title":["Tardive Dyskinesia: Nondopaminergic Treatment Approaches"],"prefix":"10.1007","author":[{"given":"D. E.","family":"Casey","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"18_CR1","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1176\/ajp.137.4.495","volume":"137","author":"NM Bacher","year":"1980","unstructured":"Bacher NM, Lewis HA (1980) Low-dose propranolol in tardive dyskinesia. Am J Psychiatry 137: 495\u2013497","journal-title":"Am J Psychiatry"},{"key":"18_CR2","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1007\/BF00427638","volume":"69","author":"N Bj\u00f8rndal","year":"1980","unstructured":"Bj\u00f8rndal N, Casey DE, Gerlach J (1980) Enkephalin, morphine, and naloxone in tardive dyskinesia. Psychopharmacology 69: 133\u2013136","journal-title":"Psychopharmacology"},{"key":"18_CR3","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1176\/ajp.138.2.189","volume":"138","author":"A Bobruff","year":"1981","unstructured":"Bobruff A, Gardos G, Tarsy D, Rapkin RM, Cole JO, Moore P (1981) Clonazepam and ph\u00e9nobarbital in tardive dyskinesia. Am J Psychiatry 138: 189\u2013193","journal-title":"Am J Psychiatry"},{"issue":"2","key":"18_CR4","first-page":"7","volume":"38","author":"DE Casey","year":"1977","unstructured":"Casey DE (1977) Deanol in the management of involuntary movement disorders: a review. Dis Nerv Syst 38 (Section 2): 7\u201315","journal-title":"Dis Nerv Syst"},{"key":"18_CR5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF00426532","volume":"54","author":"DE Casey","year":"1977","unstructured":"Casey DE, Denney D (1977) Pharmacological characterization of tardive dyskinesia. Psycho-pharmacology 54: 1\u20138","journal-title":"Psycho-pharmacology"},{"key":"18_CR6","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/978-94-011-7618-7_12","volume-title":"Guidelines for the use of psychotropic drugs","author":"DE Casey","year":"1984","unstructured":"Casey DE, Gerlach J (1984) Tardive dyskinesia: management and new treatment. In: Stancer HC, Garflnkel PE, Rakoff VM (eds) Guidelines for the use of psychotropic drugs. Spectrum, New York, pp 183\u2013203"},{"key":"18_CR7","first-page":"483","volume":"40","author":"DE Casey","year":"1979","unstructured":"Casey DE, Hammerstad JP (1979) Sodium valproate in tardive dyskinesia. J Clin Psychiatry 40: 483\u2013485","journal-title":"J Clin Psychiatry"},{"key":"18_CR8","first-page":"65","volume-title":"New directions in tardive dyskinesia research. Mod Probl Pharmacopsychiatry","author":"DE Casey","year":"1983","unstructured":"Casey DE, Toenniessen LM (1983) Neuroleptic treatment in tardive dyskinesia: can it be developed into a clinical strategy for long-term treatment? In: Bannet J, Belmaker RH (eds) New directions in tardive dyskinesia research. Mod Probl Pharmacopsychiatry 21: 65\u201379"},{"key":"18_CR9","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1001\/archpsyc.1980.01780250062007","volume":"37","author":"DE Casey","year":"1980","unstructured":"Casey DE, Gerlach J, Magelund G, Rosted Christensen T (1980) Gamma-acetylenic GABA in tardive dyskinesia. Arch Gen Psychiatry 37: 1376\u20131379","journal-title":"Arch Gen Psychiatry"},{"key":"18_CR10","first-page":"402","volume-title":"Biological psychiatry","author":"DE Casey","year":"1981","unstructured":"Casey DE, Korsgaard S, Gerlach J (1981) Destyrosine-gamma-endorphin in tardive dyskinesia. In: Perris C, StruweG, JanssonB (eds) Biological psychiatry 1981. Elsevier, New York, pp 402\u2013404 (Developments in psychiatry, vol 5 )"},{"key":"18_CR11","volume-title":"Proc Ann Meet Am Psychiatr Assoc NR54","author":"DE Casey","year":"1983","unstructured":"Casey DE, Korsgaard S, Gerlach J (1983) Tardive dyskinesia: the effect of gamma-vinyl GABA. Proc Ann Meet Am Psychiatr Assoc NR54"},{"key":"18_CR12","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1136\/jnnp.33.4.511","volume":"33","author":"GE Crane","year":"1970","unstructured":"Crane GE, Turek IS, Kurland AA (1970) Failure of pyridoxine to reduce drug-induced dyskinesias. J Neurol Neurosurg Psychiatry 33: 511\u2013512","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"18_CR13","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1016\/0024-3205(76)90095-3","volume":"19","author":"KL Davis","year":"1976","unstructured":"Davis KL, Hollister LE, Barchas JD, Berger PA (1976) Choline in tardive dyskinesia and Huntington\u2019 disease. Life Sci 19: 1507\u20131516","journal-title":"Life Sci"},{"key":"18_CR14","first-page":"573","volume":"39","author":"J Veaugh-Geiss De","year":"1978","unstructured":"DeVeaugh-Geiss J, Manion L (1978) High-dose pyridoxine in tardive dyskinesia. J Clin Psychiatry 39: 573\u2013575","journal-title":"J Clin Psychiatry"},{"key":"18_CR15","first-page":"303","volume":"38","author":"RH Ehrensing","year":"1977","unstructured":"Ehrensing RH, Kastin AJ, Larsons PF, Bishop GA (1977) Melanocyte-stimulating-hormone release-inhibiting factor-I and tardive dyskinesia. Dis Nerv Syst 38: 303\u2013307","journal-title":"Dis Nerv Syst"},{"key":"18_CR16","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1176\/ajp.137.4.527","volume":"137","author":"R Freedman","year":"1980","unstructured":"Freedman R, Bell J, Kirch D (1980) Clonidine therapy for coexisting psychosis and tardive dyskinesia. Am J Psychiatry 137: 629\u2013630","journal-title":"Am J Psychiatry"},{"key":"18_CR17","first-page":"18","volume":"14","author":"G Gardos","year":"1978","unstructured":"Gardos G, Cole JO (1978) Pilot study of cyproheptadine (periactin) in TD. Psychopharmacol Bull 14: 18\u201320","journal-title":"Psychopharmacol Bull"},{"key":"18_CR18","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1002\/j.1552-4604.1976.tb02409.x","volume":"16","author":"G Gardos","year":"1976","unstructured":"Gardos G, Cole JO, Sniffen C (1976) An evaluation of papaverine in tardive dyskinesia. J Clin Pharmacol 16: 304\u2013310","journal-title":"J Clin Pharmacol"},{"key":"18_CR19","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1176\/ajp.136.12.1612-a","volume":"136","author":"AJ Gelenberg","year":"1979","unstructured":"Gelenberg AJ, Doller-Wojcik JC, Growdon JH (1979) Choline and lecithin in the treatment of tardive dyskinesia: preliminary results from a pilot study. Am J Psychiatry 136: 772\u2013776","journal-title":"Am J Psychiatry"},{"key":"18_CR20","first-page":"209","volume":"26","author":"J Gerlach","year":"1979","unstructured":"Gerlach J (1979) Tardive dyskinesia. Dan Med Bull 26: 209\u2013245","journal-title":"Dan Med Bull"},{"key":"18_CR21","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/BF00427742","volume":"59","author":"J Gerlach","year":"1978","unstructured":"Gerlach J, Simmelsgaard H (1978) Tardive dyskinesia during and following treatment with haloperidol, haloperidol + biperiden, thioridazine, and clozapine. Psychopharmacology 59: 105\u2013112","journal-title":"Psychopharmacology"},{"key":"18_CR22","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/BF00421217","volume":"34","author":"J Gerlach","year":"1974","unstructured":"Gerlach J, Reisby N, Randrup A (1974) Dopaminergic hypersensitivity and cholinergic hypofunction in the pathophysiology of tardive dyskinesia. Psychopharmacologia 34: 21\u201335","journal-title":"Psychopharmacologia"},{"key":"18_CR23","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/BF00431840","volume":"56","author":"J Gerlach","year":"1978","unstructured":"Gerlach J, Rye T, Kristjansen P (1978) Effect of baclofen on tardive dyskinesia. Psychopharmacology 56: 145\u2013151","journal-title":"Psychopharmacology"},{"key":"18_CR24","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/BF00427612","volume":"47","author":"D Goldman","year":"1976","unstructured":"Goldman D (1976) Treatment of phenothiazine-induced dyskinesia. Psychopharmacology 47: 271\u2013272","journal-title":"Psychopharmacology"},{"key":"18_CR25","first-page":"67","volume":"2","author":"E Gomez","year":"1977","unstructured":"Gomez E (1977) Clinical observations in the treatment of tardive dyskinesia with dihydro- genated ergot alkaloids (hydergine), preliminary findings. Psychiatr J Univ Ottawa 2: 67\u201371","journal-title":"Psychiatr J Univ Ottawa"},{"key":"18_CR26","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1056\/NEJM197709082971002","volume":"297","author":"JH Growdon","year":"1977","unstructured":"Growdon JH, Hirsch MJ, Wurtman RJ, Wiener W (1977) Oral choline administration to patients with tardive dyskinesia. N Engl J Med 297: 524\u2013527","journal-title":"N Engl J Med"},{"key":"18_CR27","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1176\/ajp.136.11.1458","volume":"136","author":"IV Jackson","year":"1979","unstructured":"Jackson IV, Nuttall EA, Ibe IO, Perez-Cruet J (1979) Treatment of tardive dyskinesia with lecithin. Am J Psychiatry 136: 1458\u20131460","journal-title":"Am J Psychiatry"},{"key":"18_CR28","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1001\/archpsyc.1982.04290070037008","volume":"39","author":"DV Jeste","year":"1982","unstructured":"Jeste DV, Wyatt RJ (1982) Therapeutic strategies against tardive dyskinesia. Arch Gen Psychiatry 39: 803\u2013816","journal-title":"Arch Gen Psychiatry"},{"key":"18_CR29","first-page":"138","volume":"9","author":"K Jus","year":"1974","unstructured":"Jus K, Jus A, Gautier J, Villeneuve A, Pires P, Pineau R, Villeneuve R (1974) Studies on the action of certain pharmacological agents on tardive dyskinesia and on the rabbit syndrome. Int J Clin Pharmacol 9: 138\u2013145","journal-title":"Int J Clin Pharmacol"},{"key":"18_CR30","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1212\/WNL.32.5.547","volume":"32","author":"WC Koller","year":"1982","unstructured":"Koller WC, Barr A, Biary N (1982) Estrogen treatment of dyskinetic disorders. Neurology 32: 547\u2013549","journal-title":"Neurology"},{"key":"18_CR31","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1111\/j.1600-0447.1976.tb00090.x","volume":"54","author":"S Korsgaard","year":"1976","unstructured":"Korsgaard S (1976) Baclofen (lioresal) in the treatment of neuroleptic-induced tardive dyskinesia. Acta Psychiatr Scand 54: 17\u201324","journal-title":"Acta Psychiatr Scand"},{"key":"18_CR32","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/BF00432752","volume":"74","author":"S Korsgaard","year":"1981","unstructured":"Korsgaard S, Casey DE, Damgaard Pedersen NE, J\u00f8rgensen A, Gerlach J (1981) Vasopressin in anergic schizophrenia. A cross-over study with lysine-8-vasopressin and placebo. Psychopharmacology 74: 379\u2013382","journal-title":"Psychopharmacology"},{"key":"18_CR33","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1001\/archpsyc.1982.04290090021005","volume":"39","author":"S Korsgaard","year":"1982","unstructured":"Korsgaard S, Casey DE, Gerlach J, Hetmar O, Kaldan B, Mikkelsen LB (1982) The effect of tetrahydroisoxazolopyridinol ( THIP) in tardive dyskinesia. Arch Gen Psychiatry 39: 1017\u20131021","journal-title":"Arch Gen Psychiatry"},{"key":"18_CR34","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/0165-1781(83)90014-8","volume":"8","author":"S Korsgaard","year":"1983","unstructured":"Korsgaard S, Casey DE, Gerlach J (1983) Effect of gamma-vinyl GABA in tardive dyskinesia. Psychiatry Res 8: 261\u2013269","journal-title":"Psychiatry Res"},{"key":"18_CR35","first-page":"18","volume":"16","author":"FA Kulik","year":"1980","unstructured":"Kulik FA, Wilbur R (1980) Propranolol for tardive dyskinesia and extrapyramidal side effects (pseudoparkinsonism) from neuroleptics. Psychopharmacol Bull 16: 18\u201319","journal-title":"Psychopharmacol Bull"},{"key":"18_CR36","first-page":"4","volume":"5","author":"RA Kunin","year":"1976","unstructured":"Kunin RA (1976) Manganese and niacin in the treatment of drug-induced dyskinesias. Orthomolec Psychiatry 5: 4\u201327","journal-title":"Orthomolec Psychiatry"},{"key":"18_CR37","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1192\/bjp.129.2.114","volume":"129","author":"M Linnoila","year":"1976","unstructured":"Linnoila M, Viukari M, Hietala O (1976) Effect of sodium valproate on tardive dyskinesia. Br J Psychiatry 129: 114\u2013119","journal-title":"Br J Psychiatry"},{"key":"18_CR38","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1176\/ajp.141.3.412","volume":"141","author":"JF Lipinski","year":"1984","unstructured":"Lipinski JF, Zubenko GS, Cohen BM, Barreira PJ (1984) Propranolol in the treatment of neuroleptic-induced akathisia. Am J Psychiatry 141: 412\u2013415","journal-title":"Am J Psychiatry"},{"key":"18_CR39","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1176\/ajp.137.8.1004","volume":"137","author":"DC Moore","year":"1980","unstructured":"Moore DC, Bowers MB (1980) Identification of a subgroup of tardive dyskinesia patients by pharmacologic probes. Am J Psychiatry 137: 1202\u20131205","journal-title":"Am J Psychiatry"},{"key":"18_CR40","first-page":"437","volume-title":"Long-term effects of neuroleptics. Biochem Psychopharmacol","author":"NPV Nair","year":"1980","unstructured":"Nair NPV, Lai S, Schwartz G, Thavundayil JX (1980) Effect of sodium valproate and baclofen in tardive dyskinesia: clinical and neuroendocrine studies. In: Cattabeni F, Racagni Spano PF, Costa E (eds) Long-term effects of neuroleptics. Biochem Psychopharmacol 24: 437\u2013441"},{"key":"18_CR41","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1007\/BF00464572","volume":"77","author":"HA Nasrallah","year":"1982","unstructured":"Nasrallah HA, Smith RE, Dunner FJ, McCalley-Whitters M (1982) Serotonin precursor effects in tardive dyskinesia. Psychopharmacology 77: 234\u2013235","journal-title":"Psychopharmacology"},{"key":"18_CR42","first-page":"317","volume-title":"Choline and lecithin in brain disorders","author":"JG Nutt","year":"1979","unstructured":"Nutt JG, Tamminga CA, Eisler T, Chase TN (1979) Clinical experience with a cholinergic agonist in hyperkinetic movement disorders. In: Barbeau A, Growdon JH, Wurtman RJ (eds) Choline and lecithin in brain disorders. Raven, New York pp 317\u2013324 (Nutrition and the brain, vol 5 )"},{"key":"18_CR43","first-page":"391","volume":"18","author":"A Perenyi","year":"1983","unstructured":"Perenyi A, Farkas A (1983) Propranolol in the treatment of tardive dyskinesia. Biol Psychiatry 18: 391\u2013394","journal-title":"Biol Psychiatry"},{"key":"18_CR44","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1126\/science.566468","volume":"201","author":"A Pert","year":"1978","unstructured":"Pert A, Rosenblatt JE, Sivit C, Pert CB, Bunney WE Jr (1978) Long-term treatment with lithium prevents the development of dopamine receptor supersensitivity. Science 201: 171\u2013173","journal-title":"Science"},{"key":"18_CR45","first-page":"36","volume":"9","author":"AJ Prange","year":"1973","unstructured":"Prange AJ, Wilson IC, Morris CE, Hall CD (1973) Preliminary experience with tryptophan and lithium in the treatment of tardive dyskinesia. Psychopharmacol Bull 9: 36\u201337","journal-title":"Psychopharmacol Bull"},{"key":"18_CR46","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1017\/S0033291700046778","volume":"12","author":"SC Rastogi","year":"1982","unstructured":"Rastogi SC, Blowers AJ, Gibson AC (1982) Codergocrine (hydergine) in the treatment of tardive dyskinesia. Psychol Med 12: 427\u2013429","journal-title":"Psychol Med"},{"key":"18_CR47","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1016\/S0140-6736(79)92709-0","volume":"2","author":"AH Rosenbaum","year":"1979","unstructured":"Rosenbaum AH, de la Fuente JR (1979) Benzodiazepines and tardive dyskinesia. Lancet 2: 900","journal-title":"Lancet"},{"issue":"2","key":"18_CR48","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/0361-9230(80)90111-2","volume":"5","author":"MM Singh","year":"1980","unstructured":"Singh MM, Nasrallah HA, Lai H, Pitman RK, Becker RE, Kucharski T, Karkalas J, Fox R (1980) Treatment of tardive dyskinesia with diazepam: indirect evidence for the involvement of limbic, possibly GABA-ergic mechanisms. Brain Res Bull [Suppl 2] 5: 673\u2013680","journal-title":"Brain Res Bull"},{"key":"18_CR49","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1001\/archpsyc.1979.01780050105013","volume":"36","author":"CA Tamminga","year":"1979","unstructured":"Tamminga CA, Crayton JW, Chase TN (1979) Improvement in tardive dyskinesia after muscimol therapy. Arch Gen Psychiatry 36: 595\u2013598","journal-title":"Arch Gen Psychiatry"},{"key":"18_CR50","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/S0140-6736(83)90075-2","volume":"8341","author":"CA Tamminga","year":"1983","unstructured":"Tamminga CA, Thaker GK, Ferrano TN, Hare TA (1983) GABA agonist treatment improves tardive dyskinesia. Lancet 8341: 97\u201398","journal-title":"Lancet"},{"key":"18_CR51","first-page":"581","volume":"305","author":"GP Tell","year":"1981","unstructured":"Tell GP, Schechter PJ, Koch-Weser J (1981) Effects of gamma-vinyl GABA. N Engl J Med 305: 581\u2013582","journal-title":"N Engl J Med"},{"key":"18_CR52","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1159\/000117746","volume":"6","author":"A Villeneuve","year":"1980","unstructured":"Villeneuve A, Cazejust T, Cote M (1980) Estrogens in tardive dyskinesia in male psychiatric patients. Neuropsychobiology 6: 145\u2013151","journal-title":"Neuropsychobiology"},{"key":"18_CR53","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1111\/j.1600-0447.1977.tb06663.x","volume":"56","author":"M Viukari","year":"1977","unstructured":"Viukari M, Linnoila M (1977) Effect of fusaric acid on tardive dyskinesia and mental state in psychogeriatric patients. Acta Psychiatr Scand 56: 57\u201361","journal-title":"Acta Psychiatr Scand"},{"key":"18_CR54","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1159\/000468453","volume":"15","author":"R Yassa","year":"1980","unstructured":"Yassa R, Ananth J (1980) Lithium carbonate in the treatment of movement disorders. Int Pharmacopsychiatry 15: 301\u2013308","journal-title":"Int Pharmacopsychiatry"}],"container-title":["Psychopharmacology Supplementum","Dyskinesia"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-642-70140-5_18.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,24]],"date-time":"2020-11-24T22:45:03Z","timestamp":1606257903000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-3-642-70140-5_18"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1985]]},"ISBN":["9783642701429","9783642701405"],"references-count":54,"URL":"https:\/\/doi.org\/10.1007\/978-3-642-70140-5_18","relation":{},"ISSN":["0931-6795"],"issn-type":[{"value":"0931-6795","type":"print"}],"subject":[],"published":{"date-parts":[[1985]]}}}